Capparelli

Safety, Tolerability, Pharmacokinetics, and Immunogenicity of mAb114: A Phase 1 Trial of a Therapeutic Monoclonal Antibody Targeting Ebola Virus Glycoprotein

J. Mascola, R. Koup, N. Sullivan, 2019 .

Intravenous or Intranasal Administration of Gliadin is Able to Down‐Regulate the Specific Immune Response in Mice

F. Maurano, M. Rossi, Rossi, 1999, Scandinavian journal of immunology.